Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety

Hypochondriasis Clinical Trial

— Ha1b  

Official title:

Internet-delivered Cognitive Behavioural Therapy for Health Anxiety - a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00828152
• Other study ID #: Ha1b
• Status: Completed
• Phase: Phase 2
• First received: January 22, 2009
• Last updated: May 5, 2015
• Start date: January 2009
• Est. completion date: July 2010

Study information

• Verified date: June 2010
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Regional Ethical Review Board
• Study type: Interventional

Clinical Trial Summary

Hypochondriasis (health anxiety) is common, has many negative consequences for the afflicted individual and is associated with high societal costs. Cognitive Behavioural Therapy (CBT) has proven to be effective when administered in live-sessions. The aim of this study is to investigate whether CBT remains effective when administered via a self-help programme on the Internet.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: July 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Primary diagnosis of hypochondriasis

• At least 18 years old

• Able to read and write in swedish

• Computer access

Exclusion Criteria:

• Drug abuse

• Concurrent severe depression

• No serious somatic illness

• Previous treatment with CBT for hypochondriasis

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hypochondriasis

Intervention

Behavioral:
• Internet-delivered CBT.
12 weeks. Therapist contact through e-mail.
• On line discussion group
Placebo. On line discussion group.

Locations

Country	Name	City	State
Sweden	Psykiatri Sydväst	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health Anxiety Inventory		3 days before treatment start	No
Primary	Health Anxiety Inventory		12 weeks after pre asessment	No
Primary	Health Anxiety Inventory		6 months after post assessment	No
Primary	Health Anxiety Inventory		12 months after post assessment	No
Secondary	IAS		Immediately pre and post treatment,and 6 and 12 month follow up	No
Secondary	BAI		Immediately pre and post treatment, and 6 and 12 month follow-up	No
Secondary	MADRS-S		Immediately pre and post treatment, and 6 and 12 month follow-up	No
Secondary	QOLI		Immediately pre and post treatment, and 6 and 12 month follow-up	No
Secondary	WI		Immediately pre and post treatment, and 6 and 12 month follow-up	No